Literature DB >> 27003600

Comparison of the Phenotype and Approach to Pediatric vs Adult Patients With Nonalcoholic Fatty Liver Disease.

Valerio Nobili1, Anna Alisi1, Kimberly P Newton2, Jeffrey B Schwimmer3.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) is one of the main chronic noncommunicable diseases in Westernized societies; its worldwide prevalence has doubled during the last 20 years. NAFLD has serious health implications not only for adults, but also for children. However, pediatric NAFLD is not only an important global problem in itself, but it is likely to be associated with increases in comorbidities, such as metabolic syndrome and cardiovascular diseases. There are several differences between NAFLD in children and adults, and it is not clear whether the disease observed in children is the initial phase of a process that progresses with age. The increasing prevalence of pediatric NAFLD has serious implications for the future adult population requiring appropriate action. Studies of NAFLD progression, pathogenesis, and management should evaluate disease phenotypes in children and follow these over the patient's lifetime. We review the similarities and differences of NAFLD between children and adults.
Copyright © 2016 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adults; Children; Nonalcoholic Fatty Liver Disease; Nonalcoholic Steatohepatitis

Mesh:

Year:  2016        PMID: 27003600      PMCID: PMC4887388          DOI: 10.1053/j.gastro.2016.03.009

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  141 in total

1.  Liver transplantation for nonalcoholic steatohepatitis in young patients.

Authors:  Naim Alkhouri; Ibrahim A Hanouneh; Nizar N Zein; Rocio Lopez; Dympna Kelly; Bijan Eghtesad; John J Fung
Journal:  Transpl Int       Date:  2016-04       Impact factor: 3.782

2.  Abnormal liver function in children with metabolic syndrome from a UK-based obesity clinic.

Authors:  Christina Wei; Anna Ford; Linda Hunt; Elizabeth C Crowne; Julian P H Shield
Journal:  Arch Dis Child       Date:  2010-11-19       Impact factor: 3.791

3.  Hepatocellular ballooning in NASH.

Authors:  Stephen Caldwell; Yoshihiro Ikura; Daniela Dias; Kosuke Isomoto; Akito Yabu; Christopher Moskaluk; Patcharin Pramoonjago; Winsor Simmons; Harriet Scruggs; Nicholas Rosenbaum; Timothy Wilkinson; Patsy Toms; Curtis K Argo; Abdullah M S Al-Osaimi; Jan A Redick
Journal:  J Hepatol       Date:  2010-06-25       Impact factor: 25.083

4.  Variant in the glucokinase regulatory protein (GCKR) gene is associated with fatty liver in obese children and adolescents.

Authors:  Nicola Santoro; Clarence K Zhang; Hongyu Zhao; Andrew J Pakstis; Grace Kim; Romy Kursawe; Daniel J Dykas; Allen E Bale; Cosimo Giannini; Bridget Pierpont; Melissa M Shaw; Leif Groop; Sonia Caprio
Journal:  Hepatology       Date:  2011-12-18       Impact factor: 17.425

5.  Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents.

Authors:  Jeffrey B Schwimmer; Nancy McGreal; Reena Deutsch; Milton J Finegold; Joel E Lavine
Journal:  Pediatrics       Date:  2005-05       Impact factor: 7.124

6.  Association between metabolic syndrome and liver histology among children with nonalcoholic Fatty liver disease.

Authors:  Heather M Patton; Katherine Yates; Aynur Unalp-Arida; Cynthia A Behling; Terry T-K Huang; Philip Rosenthal; Arun J Sanyal; Jeffrey B Schwimmer; Joel E Lavine
Journal:  Am J Gastroenterol       Date:  2010-04-06       Impact factor: 10.864

7.  Vitamin E treatment in pediatric obesity-related liver disease: a randomized study.

Authors:  Pietro Vajro; Claudia Mandato; Adriana Franzese; Edmondo Ciccimarra; Stefania Lucariello; Marcella Savoia; Grazia Capuano; Fiorella Migliaro
Journal:  J Pediatr Gastroenterol Nutr       Date:  2004-01       Impact factor: 2.839

8.  SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease.

Authors:  Jeffrey B Schwimmer; Winston Dunn; Gregory J Norman; Perrie E Pardee; Michael S Middleton; Nanda Kerkar; Claude B Sirlin
Journal:  Gastroenterology       Date:  2010-01-11       Impact factor: 22.682

Review 9.  Economic and Quality-of-Life Implications of Non-Alcoholic Fatty Liver Disease.

Authors:  Zobair M Younossi; Linda Henry
Journal:  Pharmacoeconomics       Date:  2015-12       Impact factor: 4.981

10.  Non-alcoholic fatty liver disease and hepatocellular carcinoma in a 7-year-old obese boy: coincidence or comorbidity?

Authors:  V Nobili; A Alisi; C Grimaldi; D Liccardo; P Francalanci; L Monti; A Castellano; J de Ville de Goyet
Journal:  Pediatr Obes       Date:  2013-12-03       Impact factor: 4.000

View more
  39 in total

1.  Commonalities and Distinctions Between Alcoholic and Nonalcoholic Fatty Liver Disease.

Authors:  Arun J Sanyal; Philippe Mathurin; Laura A Nagy
Journal:  Gastroenterology       Date:  2016-05-04       Impact factor: 22.682

2.  Low Birthweight Increases the Likelihood of Severe Steatosis in Pediatric Non-Alcoholic Fatty Liver Disease.

Authors:  Elisabetta Bugianesi; Carla Bizzarri; Chiara Rosso; Antonella Mosca; Nadia Panera; Silvio Veraldi; Andrea Dotta; Germana Giannone; Massimiliano Raponi; Marco Cappa; Anna Alisi; Valerio Nobili
Journal:  Am J Gastroenterol       Date:  2017-05-30       Impact factor: 10.864

Review 3.  Hepatic sexual dimorphism - implications for non-alcoholic fatty liver disease.

Authors:  Philippe Lefebvre; Bart Staels
Journal:  Nat Rev Endocrinol       Date:  2021-08-20       Impact factor: 43.330

4.  Effects of serum branched-chain amino acids on nonalcoholic fatty liver disease and subsequent cardiovascular disease.

Authors:  Fei Guo; Rui Chen; Linghui Kong; Pan Wei; Ziyu Liu; Xiaoqing Wang; Hairong Hao; Yanwen Lu; Wen Hu
Journal:  Hepatol Int       Date:  2022-07-18       Impact factor: 9.029

5.  Dietary fat composition shapes bile acid metabolism and severity of liver injury in a pig model of pediatric NAFLD.

Authors:  Rodrigo Manjarín; Kayla Dillard; Morgan Coffin; Gabriella V Hernandez; Victoria A Smith; Trista Noland-Lidell; Tanvi R Gehani; Hayden J Smart; Kevin Wheeler; Kimberly A Sprayberry; Mark S Edwards; Rob K Fanter; Hunter Glanz; Chad Immoos; Tasha M Santiago-Rodriguez; Jason M Blank; Douglas G Burrin; Brian D Piccolo; Mohammed Abo-Ismail; Michael R La Frano; Magdalena Maj
Journal:  Am J Physiol Endocrinol Metab       Date:  2022-07-20       Impact factor: 5.900

6.  High-fat diet induces fibrosis in mice lacking CYP2A5 and PPARα: a new model for steatohepatitis-associated fibrosis.

Authors:  Xue Chen; George K Acquaah-Mensah; Krista L Denning; Jonathan M Peterson; Kesheng Wang; James Denvir; Feng Hong; Arthur I Cederbaum; Yongke Lu
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-09-02       Impact factor: 4.052

Review 7.  Nonalcoholic Fatty Liver Disease in Children: Not a Small Matter.

Authors:  Praveen Kumar Conjeevaram Selvakumar; Mohammad Nasser Kabbany; Naim Alkhouri
Journal:  Paediatr Drugs       Date:  2018-08       Impact factor: 3.022

Review 8.  NAFLD in children: new genes, new diagnostic modalities and new drugs.

Authors:  Valerio Nobili; Anna Alisi; Luca Valenti; Luca Miele; Ariel E Feldstein; Naim Alkhouri
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-07-05       Impact factor: 46.802

9.  A clinical model to predict fibrosis on liver biopsy in paediatric subjects with nonalcoholic fatty liver disease.

Authors:  Sakil Kulkarni; Nadia Naz; Hongjie Gu; Janis M Stoll; Michael D Thompson; Brian J DeBosch
Journal:  Clin Obes       Date:  2021-06-09

10.  A branched-chain amino acid-based metabolic score can predict liver fat in children and adolescents with severe obesity.

Authors:  Julia Lischka; Andrea Schanzer; Azadeh Hojreh; Ahmed Ba Ssalamah; Chike Bellarmine Item; Charlotte de Gier; Nina-Katharina Walleczek; Thomas F Metz; Ivana Jakober; Susanne Greber-Platzer; Maximilian Zeyda
Journal:  Pediatr Obes       Date:  2020-10-14       Impact factor: 4.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.